Supply and Administration of Freestyle Libre 3 Sensors

This tender concerns the supply and administration of Freestyle Libre 3 sensors, a medical device crucial for diabetes management. The contracting authority for this procurement is the Azienda Sanitaria Provinciale (ASP) di Messina, located in Messina, Italy. The tender, identified by CIG code BA6044DD36, falls under the category of miscellaneous medical devices and products (CPV code). The contract was awarded through a negotiated procedure without prior publication of a call for competition, indicating a specific selection process. The estimated value of the contract was EUR 89,362.00, which also corresponds to the final award value. The awarded company is Abbott S.r.l. This procurement is vital for ensuring the availability of advanced glucose monitoring technology for patients within the Messina province, supporting improved health outcomes and patient care. The Freestyle Libre 3 system represents a significant advancement in continuous glucose monitoring, offering users a less invasive and more convenient way to track their glucose levels, thereby facilitating better treatment decisions and enhancing quality of life for individuals living with diabetes. The ASP di Messina's commitment to acquiring such innovative medical supplies underscores its dedication to modernizing healthcare services and meeting the evolving needs of its patient population.

This is a supplies contract in the general supplies sector. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 89,362.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.